These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 12861516

  • 1. [Use of botulinum toxin in the preventive and palliative treatment of the hips in children with infantile cerebral palsy].
    Pascual-Pascual SI.
    Rev Neurol; ; 37(1):80-2. PubMed ID: 12861516
    [Abstract] [Full Text] [Related]

  • 2. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B, Lagueny A, Flurin V, Arnaud C, Pedespan JM, Fontan D, Pontallier JR.
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [Abstract] [Full Text] [Related]

  • 3. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
    Ibrahim AI, Hawamdeh ZM, Al-Qudah AA.
    Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT, Doherty GM, Fairhurst CB.
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [Abstract] [Full Text] [Related]

  • 5. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Sep; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
    Cardoso ES, Rodrigues BM, Barroso M, Menezes CJ, Lucena RS, Nora DB, Melo A.
    Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation and treatment of hip dysplasia in cerebral palsy.
    Spiegel DA, Flynn JM.
    Orthop Clin North Am; 2006 Apr; 37(2):185-96, vi. PubMed ID: 16638449
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H, Kotamäki A, Koivikko M, Autti-Rämö I.
    Pediatr Rehabil; 2006 Apr; 9(3):247-58. PubMed ID: 17050402
    [Abstract] [Full Text] [Related]

  • 17. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
    Papadonikolakis AS, Vekris MD, Korompilias AV, Kostas JP, Ristanis SE, Soucacos PN.
    Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Acetabuloplasty in cerebral palsy patients].
    Schejbalová A, Chládek P.
    Acta Chir Orthop Traumatol Cech; 2007 Dec; 74(6):382-7. PubMed ID: 18198087
    [Abstract] [Full Text] [Related]

  • 20. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy.
    Moore AP, Ade-Hall RA, Smith CT, Rosenbloom L, Walsh HP, Mohamed K, Williamson PR.
    Neurology; 2008 Jul 08; 71(2):122-8. PubMed ID: 18606966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.